Parmax Pharma Ltd

NSE: PARMAX · BSE: 540359 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹139.10
Market cap: ₹52.04 Cr
Revenue (annual): ₹12.11 Cr
Net profit (annual): ₹-4.16 Cr
P/E (TTM): -43.5×Sector 47.4×
Promoter holding: 64.66%+33.86% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 6 Annual General Meeting 5 Open Offer 3 Financial Results 3 Other Announcement 2 Management Change 2 Board Meeting Date 2 Promoter Selling (Off-Market) 1 Promoter Reclassification 1 Promoter Buying 1 Fund Raise 1 Debt & Borrowing 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

24 Aug 2026 17:46 IST BSE

Promoter Reclassification

Parmax Pharma Promoter Reclassification

Parmax Pharma announced the reclassification of its promoters following an open offer and share purchase agreement. Existing promoters will be reclassified under the public category.

Read the filing ↗